Ilaris 150 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FGHL4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,286
Award facts
- Contract value 100% obligated
- $29,286.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $29,286.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ILARIS 150 mg/ml vials. The award, issued on January 21, 2026, with an ultimate completion date of February 11, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to support Department of Defense pharmaceutical supply requirements globally.
DMS Pharmaceutical Group has demonstrated substantial performance as a critical supplier within the federal pharmaceutical supply chain, with a product portfolio encompassing branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company holds a single-award IDC under PPV-G GEN V with a $499,999,999 ceiling value and completion date of December 31, 2036, structured to provide firm fixed-price delivery orders for the diverse pharmaceutical needs of military healthcare facilities worldwide. No subcontractors were identified in the award documentation, indicating direct performance by the prime contractor.
Quick answers
Who was awarded contract SPE2DR26FGHL4?
SPE2DR26FGHL4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FGHL4 worth?
The government has obligated $29,286 on SPE2DR26FGHL4.
Is contract SPE2DR26FGHL4 an order under another contract?
Yes. SPE2DR26FGHL4 is a delivery order under SPE2DR25D9363, an indefinite delivery contract.
Was contract SPE2DR26FGHL4 competed?
The extent of competition for SPE2DR26FGHL4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award